Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next- Generation Sequencing Bioinformatics and Variant Interpretation  Kurtis.

Slides:



Advertisements
Similar presentations
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Advertisements

Nine Novel Germline Gene Variants in the RET Proto-Oncogene Identified in Twelve Unrelated Cases Syed A. Ahmed, Karen Snow-Bailey, W. Edward Highsmith,
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Quantification of Parvovirus B19 DNA Using COBAS AmpliPrep Automated Sample Preparation and LightCycler Real-Time PCR Stefan Schorling, Gunnar Schalasta,
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens Matthew D. Wilkerson, Jason M. Schallheim, D. Neil Hayes, Patrick.
Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice Edward Balish, Thomas Warner The American Journal of Pathology.
High-Quality Genotyping Data from Formalin-Fixed, Paraffin-Embedded Tissue on the Drug Metabolizing Enzymes and Transporters Plus Array  Hanneke I. Vos,
Carol Beadling, Tanaya L. Neff, Michael C
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Genotyping of DNA Samples Isolated from Formalin-Fixed Paraffin-Embedded Tissues Using Preamplification  Renee Baak-Pablo, Vincent Dezentje, Henk-Jan.
Sensitive Detection of KRAS Mutations in Archived Formalin-Fixed Paraffin-Embedded Tissue Using Mutant-Enriched PCR and Reverse-Hybridization  Christoph.
Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes
In Silico Proficiency Testing for Clinical Next-Generation Sequencing
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,
Separate Quality-Control Measures Are Necessary for Estimation of RNA and Methylated DNA from Formalin-Fixed, Paraffin-Embedded Specimens by Quantitative.
Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing  Ming Wang, Leire.
Cystic Fibrosis The Journal of Molecular Diagnostics
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis.
Christopher R. Cabanski, Vincent Magrini, Malachi Griffith, Obi L
Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma  Wesley O. Greaves, Shalini Verma, Keyur.
A Lean Laboratory The Journal of Molecular Diagnostics
Sensitive Detection of KRAS Mutations in Archived Formalin-Fixed Paraffin-Embedded Tissue Using Mutant-Enriched PCR and Reverse-Hybridization  Christoph.
Martin Steinau, Sonya S. Patel, Elizabeth R. Unger 
Patrick R. Murray  The Journal of Molecular Diagnostics 
Technical Reproducibility of Single-Nucleotide and Size-Based DNA Biomarker Assessment Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded Tissues 
William L. Gerald, M.D., Ph.D, 1954–2008
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and.
Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next- Generation Sequencing on a Four-Gene Panel  Ava Kwong, Vivian Y. Shin,
High-Quality Genotyping Data from Formalin-Fixed, Paraffin-Embedded Tissue on the Drug Metabolizing Enzymes and Transporters Plus Array  Hanneke I. Vos,
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin- Embedded Cutaneous Melanomas  Johanne Lade-Keller, Kirsten M. Rømer, Per.
Next-Generation Sequencing for Simultaneous Determination of Human Papillomavirus Load, Subtype, and Associated Genomic Copy Number Changes in Tumors 
Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer  Kazimierz.
Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics  Maksym.
Target-Enriched Next-Generation Sequencing Reveals Differences between Primary and Secondary Ovarian Tumors in Formalin-Fixed, Paraffin-Embedded Tissue 
Christine Formisano-Tréziny, Marina de San Feliciano, Jean Gabert 
Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis.
A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients  Stephen.
BRAF Mutation Testing in Solid Tumors
The Molecular Pathology of Primary Immunodeficiencies
Report of New Haplotype for ABCC2 Gene
An Array-Based Analysis of MicroRNA Expression Comparing Matched Frozen and Formalin-Fixed Paraffin-Embedded Human Tissue Samples  Xiao Zhang, Jiamin.
Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine  Seokhwi Kim, Charny Park, Yongick Ji, Deok G.
Ashleigh C. McEvoy, Benjamin A. Wood, Nima M. Ardakani, Michelle R
Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues  Assunta De Rienzo, Robert W. Cook, Jeff Wilkinson,
External Quality Assessment for Detection of Fetal Trisomy 21, 18, and 13 by Massively Parallel Sequencing in Clinical Laboratories  Rui Zhang, Hongyun.
The Pitfalls of Companion Diagnostics
A Variant Detection Pipeline for Inherited Cardiomyopathy–Associated Genes Using Next-Generation Sequencing  Théo G.M. Oliveira, Miguel Mitne-Neto, Louise.
Matthew D. Wilkerson, Jason M. Schallheim, D. Neil Hayes, Patrick J
Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma  Soo-Ryum Yang, Chieh-Yu Lin, Henning Stehr, Steven.
Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next- Generation Sequencing Panel  Fengqi Chang, Liu Liu, Erica Fang, Guangcheng.
Validation for Clinical Use of, and Initial Clinical Experience with, a Novel Approach to Population-Based Carrier Screening using High-Throughput, Next-Generation.
Danielle C. Smith, Alina Esterhuizen, Jacquie Greenberg 
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors  Martin Pichler, Marija Balic,
Rapid Allelic Discrimination by TaqMan PCR for the Detection of the Gilbert's Syndrome Marker UGT1A1*28  Ursula Ehmer, Tim O. Lankisch, Thomas J. Erichsen,
Statistical Treatment of Fluorescence in Situ Hybridization Validation Data to Generate Normal Reference Ranges Using Excel Functions  Allison L. Ciolino,
Karen Snow-Bailey, Ph.D., 1961–2006
Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded Specimens  Raji.
Detection of BRCA1 and BRCA2 Ashkenazi Jewish Founder Mutations in Formalin- Fixed Paraffin-Embedded Tissues Using Conventional PCR and Heteroduplex/Amplicon.
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Clinical Experience with the Cervista HPV HR Assay
Angiotensin I-Converting Enzyme
Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards 
Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell- Free Tumor DNA Measurements  Hua-Jun He, Erica V. Stein, Yves Konigshofer,
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests  Susan J. Hsiao, Mahesh M. Mansukhani,
Presentation transcript:

Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next- Generation Sequencing Bioinformatics and Variant Interpretation  Kurtis D. Davies, Midhat S. Farooqi, Mike Gruidl, Charles E. Hill, Julie Woolworth-Hirschhorn, Heather Jones, Kenneth L. Jones, Anthony Magliocco, Midori Mitui, Philip H. O'Neill, Rebecca O'Rourke, Nirali M. Patel, Dahui Qin, Erica Ramos, Michael R. Rossi, Thomas M. Schneider, Geoffrey H. Smith, Linsheng Zhang, Jason Y. Park, Dara L. Aisner  The Journal of Molecular Diagnostics  Volume 18, Issue 4, Pages 572-579 (July 2016) DOI: 10.1016/j.jmoldx.2016.03.002 Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Sample characteristics. A: Of the 24 sample file sets used in the proficiency test, 20 were derived from formalin-fixed, paraffin-embedded (FFPE) processed clinical samples, one was derived from a Diff-Quik slide processed clinical sample, and three were derived from commercially available calibrators (NA12878, HD129, and HD200). B: Disease type distribution for the 21 clinical samples. C: Distribution of the total number of variants (summary of all variants called by all institutions) reported per sample, including calibrator samples. The Journal of Molecular Diagnostics 2016 18, 572-579DOI: (10.1016/j.jmoldx.2016.03.002) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Variant allele frequency (VAF) concordance. The range of VAF (highest reported minus lowest reported) was calculated for all variants reported by at least two institutions (66 variants total). The distribution of these ranges is shown. The VAF range was ≤5% for most variants (81.8%). The Journal of Molecular Diagnostics 2016 18, 572-579DOI: (10.1016/j.jmoldx.2016.03.002) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions